Sanjay Popat, Professor at The Institute of Cancer Research, shared a post on X:
“Great to see ctDNA NGS is now fully funded by NHS England for routine blood draw at presentation of advanced NSCLC to clinic or as emergency admission
Now we need max implementation for max benefit!”
Sanjay Popat announced that NHS England now fully funds circulating tumor DNA next-generation sequencing (ctDNA NGS) for advanced NSCLC patients, whether presenting in clinic or via emergency admission. He called for broad implementation to ensure the full benefit of this policy.
More posts featuring Sanjay Popat.
